CGS-CIMB lowered its target price for Nanofilm Technologies to S$3.92 from S$4.02, citing potential higher operating expenses and revenue expectations that may take "longer to be realised" as the company focuses on its long-term growth plans. In "Business" CGS-CIMB on Friday (Jan 7) initiated coverage on Hyphens Pharma with an "add" call and target price of S$0.36. The research team believes the pharmaceutical and consumer healthcare company's share price has yet to reflect the value of its Novem acquisition. In "Business" CGS-CIMB has lowered its target price for GKE Corporation from S$0.21 to S$0.16 to reflect lower revenue and margin assumptions on the China infrastructure materials segment, the brokerage stated in a research report on Tuesday (Jan 18). In "Business" Receive top breaking news, events, ideas, and more!